This Article Order Full text via Infotrieve Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by McGregor, B. Articles by McGregor, J. Search for Related Content PubMed PubMed Citation Articles by McGregor, B. Articles by McGregor, J.

American Journal of Pathology, Vol 144, 1281-1287, Copyright © 1994 by American Society for Investigative Pathology

REGULAR ARTICLES

Thrombospondin in human glomerulopathies. A marker of inflammation and early fibrosis

B McGregor, S Colon, M Mutin, E Chignier, P Zech and J McGregor
Hopital Edouard Herriot, Lyon, France.

Extensive damage is thought to occur to endothelial cells in renal vasculitis and other glomerulopathies. The state of inflammation of these endothelial cells was investigated through the use of a panel of monoclonal antibodies (MAb) directed against thrombospondin (TSP), von Willebrand factor (vWF), integrins (alpha IIb beta 3, alpha v beta 3), CD36, and classical markers of inflammation (P-selectin, E-selectin, ICAM-1, VCAM). Results show that the anti-TSP MAb (LYP10) stains large areas of interstitium in focal sclerosis, vasculitis, membranous glomerulonephritis (GN), and diabetic GN but does not in normal kidney. In contrast, very limited areas are stained by LYP10 in minimal change nephropathy and Berger's disease. On paraffin-embedded specimens these areas stained by LYP10 appear edematous and early fibrous. Up- regulation of vWF and ICAM-1 is matched by an increased binding of LYP10 to the interstitium. In addition, fibrous crescents in injured glomeruli are stained by LYP10. This study reports for the first time an increased TSP secretion in glomerulopathies. Such TSP secretion may be part of physiological adaptive changes associated with inflammation and early fibrosis.

This article has been cited by other articles:

				Y. Ihara, S. Manabe, M. Kanda, H. Kawano, T. Nakayama, I. Sekine, T. Kondo, and Y. Ito Increased expression of protein C-mannosylation in the aortic vessels of diabetic Zucker rats Glycobiology, April 1, 2005; 15(4): 383 - 392. [Abstract] [Full Text] [PDF]

				S. Wang, J. Skorczewski, X. Feng, L. Mei, and J. E. Murphy-Ullrich Glucose Up-regulates Thrombospondin 1 Gene Transcription and Transforming Growth Factor-{beta} Activity through Antagonism of cGMP-dependent Protein Kinase Repression via Upstream Stimulatory Factor 2 J. Biol. Chem., August 13, 2004; 279(33): 34311 - 34322. [Abstract] [Full Text] [PDF]

				C. Daniel, Y. Takabatake, M. Mizui, Y. Isaka, H. Kawashi, H. Rupprecht, E. Imai, and C. Hugo Antisense Oligonucleotides Against Thrombospondin-1 Inhibit Activation of TGF-{beta} in Fibrotic Renal Disease in the Rat in Vivo Am. J. Pathol., September 1, 2003; 163(3): 1185 - 1192. [Abstract] [Full Text] [PDF]

				C. Hugo The thrombospondin 1-TGF-{beta} axis in fibrotic renal disease Nephrol. Dial. Transplant., July 1, 2003; 18(7): 1241 - 1245. [Full Text] [PDF]

				R. M. Mason and N. A. Wahab Extracellular Matrix Metabolism in Diabetic Nephropathy J. Am. Soc. Nephrol., May 1, 2003; 14(5): 1358 - 1373. [Abstract] [Full Text] [PDF]

				D.-H. KANG, A. H. JOLY, S.-W. OH, C. HUGO, D. KERJASCHKI, K. L. GORDON, M. MAZZALI, J. A. JEFFERSON, J. HUGHES, K. M. MADSEN, et al. Impaired Angiogenesis in the Remnant Kidney Model: I. Potential Role of Vascular Endothelial Growth Factor and Thrombospondin-1 J. Am. Soc. Nephrol., July 1, 2001; 12(7): 1434 - 1447. [Abstract] [Full Text] [PDF]

				M. H. Poczatek, C. Hugo, V. Darley-Usmar, and J. E. Murphy-Ullrich Glucose Stimulation of Transforming Growth Factor-{beta} Bioactivity in Mesangial Cells Is Mediated by Thrombospondin-1 Am. J. Pathol., October 1, 2000; 157(4): 1353 - 1363. [Abstract] [Full Text] [PDF]

				A. N. Vallejo, L. O. Mugge, P. A. Klimiuk, C. M. Weyand, and J. J. Goronzy Central Role of Thrombospondin-1 in the Activation and Clonal Expansion of Inflammatory T Cells J. Immunol., March 15, 2000; 164(6): 2947 - 2954. [Abstract] [Full Text] [PDF]

				D. J. CORDONNIER, N. PINEL, C. BARRO, C. MAYNARD, P. ZAOUI, S. HALIMI, B. H. DE LIGNY, Y. REZNIC, D. SIMON, and R. W. BILOUS Expansion of Cortical Interstitium Is Limited by Converting Enzyme Inhibition in Type 2 Diabetic Patients with Glomerulosclerosis J. Am. Soc. Nephrol., June 1, 1999; 10(6): 1253 - 1263. [Abstract] [Full Text]